The British Society for Rheumatology biologics register.
The British Society for Rheumatology (BSR) established a nationwide register for patients with rheumatological disorders treated with biologic agents. The register is designed as a national prospective study whose primary purpose is to assess long term toxicity from the use of these agents in routine practice. In addition, the data will be capable of addressing the benefits from their use in relation to their toxicity. One specific feature of the BSR register is the recruitment and collection of data from a parallel comparison group, comprising patients with active rheumatoid arthritis treated with conventional disease modifying agents. Both class specific and drug specific analyses of the group treated with biologicals are planned.
Watson
K
K
Epidemiology Research Unit, Manchester University Medical School, Manchester, UK.
Symmons
D
D
Griffiths
I
I
Silman
A
A
D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001688:Biological Products / Q000009:adverse effects*; D006801:Humans; D012042:Registries; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012219:Rheumatology; D012955:Societies, Medical; D006113:United Kingdom
D018501:Antirheumatic Agents; D001688:Biological Products